CYTOMX THERAPEUTICS INC (CTMX)

US23284F1057 - Common Stock

4.43  -0.07 (-1.56%)

After market: 4.69 +0.26 (+5.87%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
37.3M
-62.85%		53.2M
42.63%		101.214M
90.25%		92.361M
-8.75%
EBITDA
YoY % growth
-113.3M
-145.77%		-91.2M
19.51%		-4.309M
95.28%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-116M
-138.68%		-93.6M
19.31%		-6.484M
93.07%		-22.425M
-245.85%
Operating Margin
-310.99%-175.94%-6.41%-24.28%
EPS
YoY % growth
-1.31
-81.94%		-1.52
-16.03%		-0.02
98.68%		-0.19
-858.80%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.05
-4.86%
Revenue
Q2Q % growth		22.87M
-2.68%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.632M
53.41%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.01
102.33%		-0.030.04134.32%
Q3 2023
Q2Q % growth		 0.04
111.43%		-0.190.23120.76%
Q2 2023
Q2Q % growth		 -0.02
94.59%		-0.210.1990.44%
Q1 2023
Q2Q % growth		 -0.05
86.49%		-0.110.0653.65%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 26.607M
2,700.74%		21.464M5.143M23.96%
Q3 2023
Q2Q % growth		 26.38M
136.59%		14.424M11.956M82.89%
Q2 2023
Q2Q % growth		 24.72M
92.37%		14.159M10.561M74.59%
Q1 2023
Q2Q % growth		 23.5M
159.96%		19.98M3.52M17.62%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -90.37% 1.91% 20%
Revenue0% 13.11% 0% 18.97%